Normalized Income after Taxes: A company's after tax profit or loss smoothed out by elimination of all non-recurring items.
Coya Therapeutics, Inc. (COYA) had Normalized Income after Taxes of $-6.09M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$0.16M |
|
$-6.09M |
|
-- |
|
$0.16M |
|
$6.58M |
|
$-6.41M |
|
$0.32M |
|
$-6.09M |
|
$-6.09M |
|
$-6.09M |
|
$-6.09M |
|
$-6.09M |
|
|
Normalized Income after Taxes |
$-6.09M |
$-6.41M |
|
$-6.41M |
|
16.73M |
|
16.73M |
|
$-0.36 |
|
$-0.36 |
|
| Balance Sheet Financials | |
$33.43M |
|
$0.02M |
|
$0.02M |
|
$33.45M |
|
$4.50M |
|
-- |
|
$0.64M |
|
$5.14M |
|
$28.31M |
|
$28.31M |
|
$28.31M |
|
16.73M |
|
| Cash Flow Statement Financials | |
$-8.60M |
|
-- |
|
$0.02M |
|
$38.34M |
|
$29.76M |
|
$-8.58M |
|
$2.12M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.43 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-3920.47% |
|
-3920.47% |
|
-- |
|
-3725.17% |
|
-3725.17% |
|
$-8.60M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-21.53% |
|
-21.53% |
|
-18.22% |
|
-21.53% |
|
$1.69 |
|
$-0.51 |
|
$-0.51 |
|